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Abstract Destruction of IUB by ubiquitinylation is required for
signal-dependent activation of NF-UB. The IUBK ubiquitin-ligase
activity associated with phosphorylated IUBK (pIUBK) in HeLa
cells was almost completely lost by washing under stringent
conditions including 1 M NaCl; nevertheless, an SCFLTrCP
complex containing Skp1, Cullin-1, and F-box/WD40 protein
LTrCP was still bound to pIUBK, suggesting the existence of a
putative factor that is loosely associated with pIUBK and may
collaborate with SCFLTrCP. The factor was named IUBKE3-F1
and was partially purified from HeLa cells. Gel filtration
analysis revealed that IUBKE3-F1 has an apparent molecular
mass of approximately 300 kDa.
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1. Introduction
There is growing evidence addressing the importance of the
immediate removal of an inhibitory protein termed IUB in the
NF-UB signalling pathway, because IUB prevents nuclear
translocation of cytoplasmic NF-UB by masking the nuclear
location signal (NLS) of NF-UB [1]. The key process of the
proteolysis of IUB is thought to be the ubiquitinylation reac-
tion directed by IUBK ubiquitin (Ub)-ligase (also named
IUBKE3) capable of transferring Ub to the target IUB mole-
cule phosphorylated by IUB kinase (IKK) via E1 (Ub-activat-
ing) and E2 (Ub-conjugating) enzymes [2]. However, the mo-
lecular basis of the IUBKE3 enzyme was only recently
identi¢ed. To date, the trimer complex called SCF (Skp1,
Cdc53 or Cullin-1, and F-box/WD40-repeat protein) is known
to catalyze the ubiquitinylation of a number of short-lived
proteins responsible for the regulation of cell cycle progres-
sion [3]. At the beginning of 1998, Jiang and Struhl [4] found
the Slimb gene which negatively regulates the Wingless path-
way and Hedgehog pathway in Drosophila. Intriguingly, as
Slimb is an F-box/WD40-repeat protein, an SCF-like Ub-li-
gase was postulated to participate in the degradation of IUBK
as well as L-catenin, because of the similarity of the two
phosphorylation sites present in both IUBK and L-catenin
[5]. Before long, the SCFLTrCP complex, consisting of Skp1,
Cullin-1, and LTrCP, had been identi¢ed not only as a long-
sought IUBKE3 [6^10] but also as a Ub-ligase for L-catenin
[7,11^13].
Based on these numerous reports, it is clear that the
SCFLTrCP complex is an E3 enzyme required for the ubiquit-
inylation of IUBK, but it is still not clear whether the SCFLTrCP
complex in combination with E1 and E2 is su⁄cient for the
ubiquitinylation of IUBK. We found that the SCFLTrCP com-
plex coordinately recruited to phosphorylated IUBK (pIUBK)
induced by tumor necrosis factor K (TNF-K) stimulation was
tightly bound to pIUBK that could not be released by washing
with 1 M NaCl [14,15]. In the present study, however, we
found that this high salt treatment resulted in almost complete
loss of ubiquitinylating activity, suggesting the existence of
other factor(s) which may collaborate with SCFLTrCP for the
ubiquitinylation of pIUBK. We report here a novel factor
named IUBKE3-F1 with an apparent molecular mass of
300 kDa that is loosely bound to pIUBK, di¡ering from the
tightly associated SCFLTrCP complex.
2. Materials and methods
2.1. Cell culture and TNF-K treatment
Human HeLa-S3 cells were cultured as described before [15]. After
HeLa cells were pretreated with 50 WM of MG132 (Z-Leu-Leu-Leu-H,
Peptide Institute, Inc., Osaka) for 45 min followed by 0.25 WM of
okadaic acid (Wako, Tokyo) for 15 min, human TNF-K (Genzyme)
was added for 15 min at a ¢nal concentration of 300 U/ml.
2.2. Immunoprecipitation and ubiquitinylation assay of IUBK
Crude extracts from HeLa cells treated with TNF-K or nothing
were prepared by two di¡erent methods: under ‘stringent’ and
‘mild’ conditions. Under stringent conditions, HeLa cells (108 cells)
were lysed in 1 ml bu¡er A (50 mM Tris-HCl (pH 7.4) bu¡er con-
taining 150 mM NaCl, 0.1% Nonidet P-40, 10% glycerol, 25 mM
sodium L-glycerophosphate, 1 mM dithiothreitol (DTT), 0.1 mM phe-
nylmethylsulfonyl £uoride (PMSF), and 10 Wg/ml each of leupeptin,
aprotinin, and pepstatin A). Crude lysates were clari¢ed by centrifu-
gation at 15 000 rpm for 20 min. The HeLa extracts (10 mg) were
incubated at 4‡C for 16 h with 1 Wg of a rabbit polyclonal antibody
against the carboxy-terminus of IUBK (amino acids 297^317, c-21,
Santa Cruz Biotechnology) and protein A-Sepharose. The immune
complexes were then washed four times with bu¡er A. The resulting
immunoprecipitates from TNF-K-treated or untreated HeLa cells were
referred to as IP-pIUBK(s) and IP-IUBK(s), which are the phospho-
rylated and non-phosphorylated form, respectively.
Under mild conditions, HeLa cells were suspended in bu¡er B
(50 mM Tris-HCl (pH 7.4) bu¡er containing 1 mM EGTA, 2 mM
DTT, 25 mM sodium L-glycerophosphate, 0.1 mM PMSF, and 10 Wg/
ml each of leupeptin, aprotinin, and pepstatin A) and then immedi-
ately lysed in a glass Dounce homogenizer. Immunoprecipitations
were performed as previously described. The resulting immunoprecip-
itates from non-stimulated and TNF-K-treated HeLa cell extracts
were referred to as IP-IUBK(m) and IP-pIUBK(m), respectively. In
some experiments, the immunoprecipitates were further washed with
bu¡er B containing 1.0 M NaCl or 1.0 M NaH2PO4 (pH 7.4). The
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slurries of these immunoprecipitates, prepared under ‘mild’ and ‘strin-
gent’ conditions, were used for the ubiquitinylation assay as described
previously [14].
3. Results
3.1. Loss of ubiquitinylating activity of pIUBK
immunoprecipitates by 1 M NaCl wash
IUBK and pIUBK were prepared by immunoprecipitation
(IP) using anti-IUBK antibody from non-stimulated and
TNF-K-treated HeLa cell extracts under the ‘mild’ conditions
described in Section 2. These IP-IUBK and IP-pIUBK prepa-
rations (hereafter referred to as IP-IUBK(m) and IP-pIUBK(m),
respectively) were used as substrates in a ubiquitinylation as-
say. As previously reported [14], incubation of IP-pIUBK(m)
with Ub, ATP, recombinant E1 and E2 (Ubch4) enzymes was
su⁄cient to produce poly-ubiquitinylation of pIUBK without
any other supplement (see Fig. 1, lanes indicated as 0.15 M
NaCl). These ubiquitinylated proteins were detected by West-
ern analysis with anti-IUBK antibody. In contrast, Ub-ligated
bands were not detected for the non-phosphorylated form of
IP-IUBK(m). This reaction requires only E1, E2, and Ub,
which suggests that a presumptive IUBK-Ub ligase (equivalent
to IUBKE3) is tightly associated with IP-pIUBK(m) in vivo, as
previously reported [14].
Conditions necessary for dislodging this putative IUBKE3
from the associated IP-pIUBK(m) were assessed by washing
the complexes with a high-concentration salt solution. As
shown in Fig. 1, when IP-IUBK(m) was washed extensively
with a bu¡er containing 1.0 M NaCl, the poly-ubiquitinyla-
tion activity was almost completely lost. Subsequently, the
materials dissociated by washing IP-pIUBK(m) with 1.0 M
NaCl were collected, concentrated, and designated 1.0 M
NaCl extracts. These 1.0 M NaCl extracts supported fair
amounts of poly-ubiquitinylation of 1.0 M NaCl-washed IP-
pIUBK(m) having no ubiquitinylation activity, but showed no
stimulating e¡ect on the non-phosphorylated IP-IUBK(m).
These reconstitution results suggest a reversible association
of a putative IUBK-Ub ligase with pIUBK.
3.2. Identi¢cation of a novel 300-kDa factor required for
ubiquitinylation of IUBK
To further characterize this putative IUBK-Ub ligase, we
attempted to isolate it from HeLa cell extracts. Phosphoryl-
ated IUBK was prepared by immunoprecipitation from TNF-
K-treated HeLa cell extracts under ‘stringent’ conditions as
described in Section 2. The resulting immunoprecipitates,
named IP-pIUBK(s), had no E3-like activity in concerted
with E1, E2, and Ub, as similarly seen in 1.0 M NaCl-washed
IP-pIUBK(m), and were used routinely as substrates in the
IUBK ubiquitinylation assay.
Crude protein extracts prepared from a 3.0-l culture of
TNF-K-treated HeLa cells were applied directly to a chroma-
tographic column containing Sephacryl S300. Aliquots of in-
dividual fractions were tested for ubiquitinylation activity
with IP-pIUBK(s). The presumptive IUBKE3 activity, which
formed high-molecular-weight IUBK bands, eluted around
fraction 28 (Fig. 2A). The size of this IUBKE3 enzyme was
estimated to be approximately 300 kDa by comparison with
molecular marker proteins (Fig. 2B). At this point, we provi-
sionally referred to this 300-kDa factor as IUBKE3-F1, be-
cause this factor functions as an IUBK-Ub ligase E3 collabo-
rating with E1 and E2. Pooled peak fractions from Sephacryl
S-300 chromatography were then separated by DEAE-5PW
anion-exchange chromatography. A single peak for the
IUBKE3-F1 activity eluted around 0.25 M NaCl at fraction
25 (Fig. 2C). We used this peak fraction from DEAE-5PW
chromatography as the enzyme source for the characterization
of IUBKE3-F1 without further puri¢cation.
To con¢rm whether the multiple high-molecular-weight
bands detected immunochemically are actually due to poly-
ubiquitinylation of IUBK, we replaced Ub with biotin-tagged
Fig. 1. Dissociation of IUBK-Ub ligase from IP-pIUBK(m) by a 1.0 M NaCl wash. IP-IUBK(m) and IP-pIUBK(m) were washed with 1.0 M
NaCl. Materials dissociated were pooled, concentrated, and designated 1.0 M NaCl extracts. The ubiquitinylation assay was carried out by in-
cubating with ATP and the indicated combinations (+/3) of E1, (His)6-Ubch4 (E2), or Ub using 1.0 M NaCl-washed IP-pIUBK(m) or IP-
IUBK(m) as the substrate in the presence or absence of 1.0 M NaCl extract. As controls, 0.15 M NaCl-washed IP-pIUBK and IP-IUBK were
used. After terminating the reaction by the addition of a sample bu¡er for SDS-PAGE, the reaction mixtures were separated by SDS-PAGE
on a 10% gel followed by Western blotting with anti-IUBK antibody. Multiple ubiquitinylated IUBK bands with higher molecular masses were
detected by Western analysis and are designated (Ub)n-IUBK.
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Ub and assayed the ubiquitinylation reaction. As shown in
Fig. 2D, larger multiple bands of biotinylated Ub-IUBK com-
plex were detected. This reaction was defective in the absence
of E1, E2, or IUBKE3-F1. Thus, we concluded that the ob-
served high-molecular-weight bands were poly-ubiquitinylated
IUBK whose formation requires E1, E2, IUBKE3-F1, ATP,
and Ub.
When the IP-pIUBK(m) was washed extensively with a
bu¡er containing 1.0 M NaCl (as described in Fig. 1) or
1.0 M NaH2PO4, the E3-like activity was almost completely
lost (Fig. 3). This loss of E3-like activity in IP-pIUBK(m)
washed with either of these high-concentration salt solutions
was restored by the addition of partially puri¢ed IUBKE3-F1.
Taken together, these results indicate that the enzymatically
active IUBK-Ub ligase contains a certain factor(s) that is
loosely associated with IP-pIUBK(m), but not IP-IUBK(m),
and that the putative enzyme dissociated by washing
IP-pIUBK(m) with a high-concentration salt solution is func-
tionally equivalent to isolated IUBKE3-F1.
Fig. 2. Partial puri¢cation of an IUBKE3-F1 necessary for IUBK ubiquitinylation. A: Molecular sieve chromatography on a Sephacryl S-300
HR 16/60 column of HeLa cell extracts. Two-milliliter fractions were collected, and 6-Wl aliquots of each fraction were used in an ubiquitinyla-
tion assay with an IP-pIUBK(s) substrate prepared from TNF-K-treated HeLa cell extracts under ‘stringent’ conditions. Western analysis was
performed on the reaction products. The positions of molecular mass markers are shown on the left. B: Molecular mass estimation of IUBKE3-
F1 (dotted line). Thyroglobulin (669 kDa), ferritin (440 kDa), catalase (232 kDa), IgG (150 kDa), and bovine serum albumin (67 kDa) were
used as molecular mass standards. C: DEAE-5PW anion-exchange chromatography. The pooled peak fractions from Sephacryl S300 chroma-
tography were dialyzed against 50 mM Tris-HCl bu¡er (pH 7.9) containing 1 mM DTT and then loaded onto a DEAE-5PW column. The ad-
sorbed proteins were eluted by a linear gradient of 0^500 mM NaCl in the same bu¡er. One-milliliter fractions were collected, and 6 Wl of each
fraction was assayed for ubiquitinylation activity as in A. Fractions containing IUBKE3-F1 activity were pooled. D: Identi¢cation of poly-ubiq-
uitinylated IUBK. As a substrate in the ubiquitinylation assay, biotinylated Ub was used instead of Ub in the various reaction mixtures as indi-
cated. After incubation, the mixtures were analyzed by immunoblotting with horseradish peroxidase-conjugated streptavidin. The resulting poly-
biotinylated Ubs are designated (Biotin-Ub)n.
FEBS 22615 16-9-99
H. Suzuki et al./FEBS Letters 458 (1999) 343^348 345
3.3. IUBKE3-F1 is active for ubiquitinylation of phosphorylated
IUBK irrespective of TNF-K stimulation
We next tested whether or not TNF-K stimulation is re-
quired for IUBKE3-F1 activity. An IUBKE3-F1 fraction was
isolated from either TNF-K-treated or non-treated HeLa cells
and assayed for ubiquitinylation activity in the presence of E1
and E2. As shown in Fig. 4, IUBKE3-F1 isolated from un-
treated or TNF-K-treated cells exhibited high activity on the
poly-ubiquitinylation of IP-pIUBK(s). The pattern of poly-
ubiquitinylated bands was apparently the same when
IUBKE3-F1 isolated from either TNF-K-treated or non-treated
cells was used. When non-phosphorylated IP-IUBK(s) was
used as a substrate, no ubiquitinylation was observed by ad-
dition of IUBKE3-F1. These ¢ndings indicate that IUBKE3-F1
is constitutively active. Indeed, the elution pro¢les of crude
IUBKE3-F1 extracts prepared from HeLa cells treated with
either TNF-K or nothing from Sephacryl S-300 and DEAE-
5PW columns were indistinguishable (data not shown).
3.4. IUBKE3-F1 is di¡erent from the SCF complex
It is important to examine whether or not IUBKE3-F1 is
identical to the SCF complex known as the component of a
Fig. 3. IUBKE3-F1 restores the lost auto-ubiquitinylating activity of IP-pIUBK(m) caused by a 1.0 M NaCl wash. IP-IUBK(m) and IP-pIUBK(m)
were washed with a bu¡er containing 1.0 M NaCl or 1.0 M NaH2PO4 as indicated. These IP-IUBKs were used in ubiquitinylation assays with
or without IUBKE3-F1.
Fig. 4. Phosphorylation is required for IUBKE3-F1-dependent ubiquitinylation of IUBK, independent of TNF-K-treatment. Using the procedure
described in Fig. 2A,C, IUBKE3-F1 was prepared from extracts of HeLa cells treated with either TNF-K or nothing, designated (+TNF-K) and
(3TNF-K), respectively. Both IP-IUBK(s) and IP-pIUBK(s) were incubated with E1, E2, ATP, and the indicated combinations of Ub and
IUBKE3-F1s. Immunoblotting was performed with an anti-IUBK antibody.
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ubiquitinylation ligase of IUBK. For this, we performed im-
munoblot analysis using antibodies against Cullin-1 and Skp1
which are integral components of the SCF complex. As shown
in Fig. 5A, no signi¢cant immunoreactive bands were detected
in the isolated IUBKE3-F1 preparation, although these two
antibodies reacted clearly with the crude extracts of HeLa
cells, indicating that IUBKE3-F1 does not contain components
of the SCF complex.
Subsequently, we examined whether or not IUBKE3-F1 is
functionally equivalent to the SCF ligase. As reported previ-
ously [14], IP-pIUBK(m), but not IP-IUBK(m), caused poly-
ubiquitinylation of in vitro translated 35S-IUBK in the pres-
ence of IKK, E1 and E2. In contrast, IUBKE3-F1 did not
exhibit any activity (Fig. 5B). These experiments were con-
ducted in the presence of in vitro translated 35S-RelA (p65
component of NF-UB) to appropriate in vivo conditions,
but the same results were obtained in the absence of 35S-
RelA (data not shown). These results indicate that in addition
to IUBKE3-F1, some other factor necessary for ubiquitinyla-
tion of pIUBK is associated ¢rmly with IP-pIUBK(m), but not
with IP-IUBK(m). This presumptive factor is clearly di¡erent
from IUBKE3-F1, which is only loosely associated with
pIUBK. Thus, the ubiquitinylation of pIUBK de¢nitely requires
IUBKE3-F1 and the cooperative factor bound tightly to
pIUBK, which is assumed to be an SCFLTrCP complex [15].
4. Discussion
Previously, we found that the very active IUBK Ub-ligase is
selectively associated with pIUBK induced by treatment of
TNF-K to direct its poly-ubiquitinylation [14]. The initial ob-
servation of the present work was the ¢nding that the IUBK
Ub-ligase activity was lost almost completely upon washing
IP-pIUBK(m) with high-concentration salt solutions (Figs. 1
and 3), suggesting the existence of a loosely bound factor
responsible for IUBK ubiquitinylation. Currently there is ac-
cumulating evidence that SCFLTrCP, consisting of Skp1, Cull-
in-1, and LTrCP, functions as a Ub-ligase for IUBK [6^10] and
L-catenin [7,11^13], as mentioned in Section 1. However,
SCFLTrCP is known to be tightly associated with pIUBK with-
out releasing by treatment with high salts [15], suggesting that
there may be present some other factor(s), di¡ering from
SCFLTrCP, which would collaborate with SCFLTrCP ligase.
Based on these circumstances, we found a novel factor
termed IUBKE3-F1 with an molecular mass of 300 kDa
(Fig. 2) that may be required for signal-dependent ubiquitinyl-
ation of pIUBK. IUBKE3-F1 also is recruited to be associated
with pIUBK in response to treatment with TNF-K, like
SCFLTrCP [14], but the activity itself is independent of the
external signal, because apparently similar activity capable
of assisting the poly-ubiquitinylation of pIUBK was observed
for IUBKE3-F1 from both TNF-K-stimulated or unstimulated
HeLa cells (Fig. 4). It is clear that IUBKE3-F1 di¡ers from the
SCFLTrCP complex. First, IUBKE3-F1, but not SCFLTrCP, was
dissociated from pIUBK(m) by treatment with high-concentra-
tion salts, implying that it is only loosely associated with
pIUBK. Second, no measurable Cullin-1 and Skp1, compo-
nents of the SCFLTrCP complex, were detected in the partially
puri¢ed IUBKE3-F1 preparation by immunoblot analysis us-
ing anti-Cullin-1 and anti-Skp1 antibodies (Fig. 5A). In addi-
tion, IP-pIUBK(m) was assessed for the ability to ubiquitin-
ylate in vitro translated 35S-labeled IUBK, pre-phosphorylated
by puri¢ed IKK, whereas IUBKE3-F1 did not cause this poly-
ubiquitinylation of 35S-pIUBK (Fig. 5B), implying that
Fig. 5. IUBKE3-F1 di¡ers from the SCF complex. A: Samples of HeLa cell extracts (8 Wg) or partially puri¢ed IUBKE3-F1 (the pooled peak
fractions from DEAE chromatography, see Fig. 2C) (2 Wg) were used for immunoblot analysis with anti-Cullin-1 and-Skp1 antibodies as indi-
cated. An asterisk indicates an artifact band by anti-Skp1 antibody. B: IP-pIUBK(m), but not IUBKE3-F1, mediated poly-ubiquitinylation of in
vitro translated 35S-pIUBK. IUBK and RelA (the p65 component of NF-UB) were co-translated in vitro using a wheat-germ lysate translation
system in the presence of [35S]methionine and [35S]cysteine. These radioactive proteins were preincubated with IKK and ATP, and assayed for
ubiquitinylation after addition of IUBKE3-F1, IP-IUBK(m) and IP-pIUBK(m) as indicated (+/3). The reaction mixtures were then subjected
to SDS-PAGE and autoradiographed [14]. Positions of molecular mass markers, 35S-RelA, 35S-IUBK and 35S-pIUBK, and poly-ubiquitinylated
35S-IUBK are shown.
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IUBKE3-F1 alone is insu⁄cient for the Ub-ligase activity of
pIUBK, which requires another factor for full function.
Consistent with this notion, we assume that IUBKE3-F1
plays an essential role for the IUB degrading pathway by
cooperating with SCFLTrCP to form the ultimate active Ub-
IUBK ligase complex. Quite recently, another factor named
yeast Rbx1 [16,17] and its mammalian homologue ROC1
[18,19] have been found as a fourth component of the SCF
complex, which plays an indispensable role for poly-ubiquiti-
nylation of speci¢c targets, such as G1 cyclin and IUBK. The
relationship between these newly identi¢ed factors and the
presently described IUBKE3-F1 is unknown, but they are un-
likely to be identical, because the new factor was reported to
be tightly associated with Cullin-1. Further puri¢cation of
IUBKE3-F1, which is in progress, is required to clarify this
issue. It is also unknown whether IUBKE3-F1 is involved in
the ubiquitinylation of L-catenin which is known to be ubiq-
uitinylated by the same IUBKE3-SCFLTrCP complex [7,11^13].
Whether the presently described IUBKE3-F1 has a common
function for various SCF species containing many types of F-
box protein ligases (reviewed in [20^22]) awaits further study.
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